Parkinson Disease Psychosis Clinical Trials

13 clinical trials for Parkinson Disease Psychosis across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases — RECRUITING · PHASE4
• Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis — RECRUITING · PHASE2
• A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418 — RECRUITING · PHASE1
• Effect of Food and Age on the Pharmacokinetics of LY03017 — NOT_YET_RECRUITING · PHASE1
• Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis — COMPLETED · PHASE4
• A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis — COMPLETED · PHASE2
• Bioequivalence Study of Pimavanserin 34 mg Capsule — COMPLETED · PHASE1
• A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis — WITHDRAWN · PHASE2
• Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD) — COMPLETED
• The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study — TERMINATED
• Hallucinations in Parkinson's Disease — OTHER · NA
• Presence Hallucination in Parkinson's Disease — OTHER · NA
• SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis — OTHER · PHASE1

Refine this search